胎儿心脏介入治疗现状及展望

周开宇,华益民

中国当代儿科杂志 ›› 2011, Vol. 13 ›› Issue (6) : 527-531.

PDF(922 KB)
PDF(922 KB)
中国当代儿科杂志 ›› 2011, Vol. 13 ›› Issue (6) : 527-531.
综述

胎儿心脏介入治疗现状及展望

  • 周开宇,华益民
作者信息 +

Present status and prospects of fetal intervention

  • ZHOU Kai-Yu, HUA Yi-Min
Author information +
文章历史 +

摘要

Abstract

No abstract avaibale

引用本文

导出引用
周开宇,华益民. 胎儿心脏介入治疗现状及展望[J]. 中国当代儿科杂志. 2011, 13(6): 527-531
ZHOU Kai-Yu, HUA Yi-Min. Present status and prospects of fetal intervention[J]. Chinese Journal of Contemporary Pediatrics. 2011, 13(6): 527-531
中图分类号: R72   

参考文献

[1]Marshall AC, van der Velde ME, Tworetzky W, Gomez CA, Wilkins-Haug L, Benson CB, et al. Creation of an atrial septal defect in utero for fetuses with hypoplastic left heart syndrome and intact or highly restrictive atrial septum[J]. Circulation, 2004, 110(3): 253-258.

[2]Mizrahi-Arnaud A, Tworetzky W, Bulich LA, Wilkins-Haug LE, Marshall AC, Benson CB, et al. Pathophysiology, management, and outcomes of fetal hemodynamic instability during prenatal cardiac intervention[J]. Pediatr Res, 2007, 62(3): 325-330.

[3]Marshall AC, Levine J, Morash D, Silva V, Lock JE, Benson CB, et al. Results of in utero atrial septoplasty in fetuses with hypoplastic left heart syndrome[J]. Prenat Diagn, 2008, 28(11): 1023-1028.

[4]Tworetzky W, McElhinney DB, Marx GR, Benson CB, Brusseau R, Morash D, et al. In utero valvuloplasty for pulmonary atresia with hypoplastic right ventricle: techniques and outcomes[J]. Pediatrics, 2009, 124(3): e510-e518.

[5]McElhinney DB, Marshall AC, Wilkins-Haug LE, Brown DW, Benson CB, Silva V, et al. Predictors of technical success and postnatal biventricular outcome after in utero aortic valvuloplasty for aortic stenosis with evolving hypoplastic left heart syndrome[J]. Circulation, 2009, 120(15): 1482-1490.

[6]Kunisaki SM, Jennings RW. Fetal surgery[J]. J Intensive Care Med, 2008, 23(1): 33-51.

[7]Cortes RA, Farmer DL. Recent advances in fetal surgery[J]. Semin Perinatol, 2004, 28(3): 199-211.

[8]Gurtner GC, Werner S, Barrandon Y, Longaker MT. Wound repair and regeneration[J]. Nature, 2008,  453(7193): 314-321.

[9]Ahuja P, Sdek P, MacLellan WR. Cardiac myocyte cell cycle control in development, disease, and regeneration[J]. Physiol Rev, 2007, 87(2): 521544.

[10]Eibschitz I, Abinader EG, Klein A, Sharf M. Intrauterine diagnosis and control of fetal ventricular arrhythmia during labor[J]. Am J Obstet Gynecol, 1975, 122(5): 597-600.

[11]Newburger JW, Keane JF. Intrauterine supraventricular tachycardia[J]. J Pediatr, 1979, 95(5 Pt 1): 780-786.

[12]van den Heuvel F, Bink-Boelkens MT, du Marchie Sarvaas GJ, Berger RM. Drug management of fetal tachyarrhythmias: are we ready for a systematic and evidence-based approach?[J]. Pacing Clin Electrophysiol, 2008, 31(Suppl 1): S54-S57.

[13]Strasburger JF, Cuneo BF, Michon MM, Gotteiner NL, Deal BJ, McGregor SN, et al. Amiodarone therapy for drug-refractory fetal tachycardia[J]. Circulation, 2004, 109(3): 375-379.

[14]Jaeggi ET, Fouron JC, Silverman ED, Ryan G, Smallhorn J, Hornberger LK. Transplacental fetal treatment improves the outcome of prenatally diagnosed complete atrioventricular block without structural heart disease[J]. Circulation,  2004, 110(12): 1542-1548.

[15]Friedman DM, Kim MY, Copel JA, Llanos C, Davis C, Buyon JP. Prospective evaluation of fetuses with autoimmune-associated congenital heart block followed in the PR Interval and Dexamethasone Evaluation (PRIDE) Study[J]. Am J Cardiol, 2009, 103(8): 1102-1106.

[16]Olus A, Julene SC. Fetal dysrhythmias[J]. Best Pract Res Clin Obstet Gynaecol, 2008, 22(1): 31-48.

[17]McElhinney DB, Tworetzky W, Lock JE. Current status of fetal cardiac intervention[J]. Circulation, 2010, 121(10): 1256-1263.

[18]Harrison MR, Keller RL, Hawgood SB, KittermanJA, Sandberg PL, Farmer DL, et al. A randomized trial of fetal endoscopic tracheal occlusion for severe congenital diaphragmatic hernia[J]. N Engl J Med, 2003, 349(20): 1916-1924.

[19]Carpenter R, Strasburger JF, Garson A, Smith RT, Deter RL, Englehardt H. Fetal ventricular pacing for hydrops secondary to complete atrioventricular block[J]. J Am Coll Cardiol, 1986, 8(6): 1434-1436.

[20]Evgueni F, Howard AC, DaeGyun P, Daniel HZ, Bettina FC, Vicki LM, et al. Ultrasonic biophysical  measurements in the normal human fetus for optimal design of the monolithic fetal pacemaker[J]. Am J Cardiol, 2005, 95(10): 1267-1270.

[21]Kohl T, Witteler R, Strümper D, Gogarten W, Asfour B, Reckers J, et al. Operative techniques and strategies for minimally invasive fetoscopic fetal cardiac interventions in sheep[J]. Surg Endosc, 2000, 14(5): 424-430.

[22]Kohl T, Westphal M, Strümper D, Achenbach S, Halimeh S, Petry P, et al. Multimodal fetal transesophageal echocardiography for fetal cardiac intervention in sheep[J]. Circulation, 2001, 114(15): 1757-1760.

[23]Kohl T, Breuer J, Heep A. Fetal transesophageal echocardiography during balloon valvuloplasty for severe aortic valve stenosis at 28+6 weeks of gestation[J]. J Thorac Cardiovasc Surg, 2007, 134(1): 256-257.

[24]Tworetzky W, Wilkins-Haug L, Jennings RW, van der Velde ME, Marshall AC, Marx GR, et al. Balloon dilation of severe aortic stenosis in the fetus: potential for prevention of hypoplastic left heart syndrome: candidate selection, technique, and results of successful intervention[J]. Circulation,  2004, 110(15): 2125-2131.

[25]Makikallio K, McElhinney DB, Levine JC, Marx GR, Colan SD, Marshall AC, et al. Fetal aortic valve stenosis and the evolution of hypoplastic left heart syndrome: patient selection for fetal intervention[J]. Circulation, 2006, 113(11): 1401-1405.

[26]Mary TD, Yvonne AB, William BM. Diagnosis and management of restricted or closed foramen ovale in fetuses with congenital heart disease[J]. Am J Cardiol, 2004, 94(10): 1348-1351.

[27]Neda FM, Anne PO, Lawrence B, Micheal AK, Ranae LL. Scoring system to determine need for balloon atrial eptostomy for restrictive interatrial communication in infants with hypoplastic left heart syndrome[J]. J Heart Lung Transplant, 2003, 22(8):883-888.

[28]Schneider C, McCrindle BW, Carvalho JS, Hornberger LK, McCarthy KP, Daubeney PE. Development of Z-scores for fetal cardiac dimensions from echocardiography[J]. Ultrasound Obstet Gynecol, 2005, 26(6): 599-605.

[29]Huhta J, Quintero RA, Suh E. Advances in fetal cardiac intervention[J]. Cardiovasc Med, 2004, 16(5):487-493.

[30]华益民,周开宇,石晓青, 王一斌,郑植,张兴,等.妊娠中晚期胎羊宫内心脏介入治疗实验[J]. 中国组织工程研究与临床康复[J]. 2008, 12 (48), 9434-9438.

[31]周开宇,华益民,郑植, 石晓青, 王一斌, 张兴,等.胎儿心脏介入手术动物模型的建立[J]. 四川大学学报(医学版), 2008,39(4):641-644.

[32]Schmidt M, Jaeggi E, Ryan G, Hyldebrandt J, Lilly J, Peirone A, et al. Percutaneous ultrasound-guided stenting of the atrial septum in fetal sheep[J]. Ultrasound Obstet Gynecol, 2008, 32(7): 923-928.

[33]Miranda-Carus ME, Boutjdir M, Tseng CE, DiDonato F, Chan EK, Buyon JP. Induction of antibodies reactive with SSA/Ro-SSB/La and development of congenital heart block in a murine model[J]. J Immunol, 1998, 161(11): 5886-5892.

[34]Dimas VV, Taylor MD, Cunnyngham CB, Overholt ED, Bourne DW, Stanely JR 3rd, et al. Transplacental pharmacokinetics of flecainide in the gravid baboon and fetus[J]. Pediatr Cardiol, 2005, 26(6):815-820.

PDF(922 KB)

Accesses

Citation

Detail

段落导航
相关文章

/